A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (Phase 3) (TO BE DELETED METADATA)

syn66496324

Created By Orca Service orca-service

url: https://fair.dap.c-path.org/#/data/datasets/src_als_1003_2025_04_17
title: A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With ALS (FORTITUDE-ALS)
sameAs: cpath:1817
source: Critical Path Institute
creator: Cytokinetics, Inc.
species: Homo sapiens
subject: amyotrophic lateral sclerosis
keywords: Amyotrophic Lateral Sclerosis Reldesemtiv Placebo Phase 3 ALSFRS-R CK-2127107
publisher: Critical Path Institute
collection: ALS Knowledge Portal

A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (Phase 3) (TO BE DELETED METADATA) page is loading…